Skip to main content

Coronavirus (COVID-19): Visitor Restrictions, Resources, and Updates

Explore URMC
menu

Dongmei Li, Ph.D.

Contact Information

Biography

Professional Background

Dongmei Li received her PhD in Biostatistics from Department of Statistics at The Ohio State University in 2009. Her doctoral research focus on resampling-based multiple testing procedures with applications to microarray data analysis. Dr. Li's research focus on differential analysis methods and multiple testing procedures in genomic data analysis especially in methylation and transcriptome data analysis. Dr. Li also has extensive collaboration experience. She has collaborated with numerous investigators from a variety of schools and institutions such as school of medicine, nursing and dental hygiene, biomedical engineering, education, cancer center, center on disability studies, and institute of marine biology. Dr. Li has served as co-investigators and biostatisticians on multiple national grants including a 10 million grant from CMS on diabetes studies for Medicaid beneficiaries, NIH R21, P20, P30, and U54 grants on biomedical research. Dr. Li currently directs the Biomedical Data Science Certificate Program and is the Biostatistics and Informatics Core director for the WNY Center for Research on Flavored Tobacco Products (CRoFT), a center grant funded by FDA/NCI.

Credentials

Education

2006
MS | The Ohio State University
Statistics

2009
PhD | The Ohio State University
Biostatistics

Publications

Journal Articles

6/24/2020
"User Perceptions of Different Electronic Cigarette Flavors on Social Media: Observational Study." Journal of medical Internet research.. 2020 Jun 24; 22(6):e17280. Epub 2020 Jun 24.

6/22/2020
"A Social Media Study on the Associations of Flavored Electronic Cigarettes With Health Symptoms: Observational Study." Journal of medical Internet research.. 2020 Jun 22; 22(6):e17496. Epub 2020 Jun 22.

3/18/2020
Hilchey SP, Palshikar MG, Emo JA, Li D, Garigen J, Wang J, Mendelson ES, Cipolla V, Thakar J, Zand MS. "Cyclosporine a directly affects human and mouse b cell migration in vitro by disrupting a hIF-1 ?dependent, o sensing, molecular switch." BMC immunology. 2020 Mar 18; 21(1):13. Epub 2020 Mar 18.

VIEW ALL PUBLICATIONS